Temasek’s $73 Million Investment in Integrace and True North

Khaitan & Co advised True North Fund VI LLP and Integrace Private Limited in the deal.

True North Fund VI LLP and Integrace Private Limited received an investment from Temasek (through V-Sciences Investments Pte. Ltd.) in Integrace through a combination of secondary sale of a part of True North’s shares to Temasek and primary infusion of capital by Temasek in Integrace, for a total consideration of approximately INR 540 crore (approx. $73 million).

Integrace is a therapy focused healthcare company providing novel solutions in the management of Musculoskeletal Disorders Pain Management and Women Health. With its focused therapy approach- the portfolio built to address Bone & joint disorders Women Nutrition and Pregnancy.
V-Sciences Investments Pte. Ltd. is Temasek’s investment vehicle for this transaction.

The Khaitan & Co team was led by Partner Niren Patel (Picture) and Saswat Subasit (Partner), along with Lipi Rawat (Senior Associate and, Ravali Rayaprolu (Associate). Intellectual Property: Adheesh Nargolkar (Partner), Sourav Dan (Principal Associate) and Saumya Gupta (Associate). Employment Law: Anshul Prakash (Partner), Abhimanyu Pal (Principal Associate), Kosheel Gupta (Associate) and Kruthi Murthy (Associate). Corporate and other aspects: Abhilasha Vyas (Associate), Ayesha Bhattacharya (Associate), Noyonika Nair (Associate), Rohan Jhaveri (Associate) and Ruturaj Jere (Associate).

Involved fees earner: Ayesha Bhattacharya – Khaitan & Co.; Sourav Dan – Khaitan & Co.; Saumya Gupta – Khaitan & Co.; Kosheel Gupta – Khaitan & Co.; Ruturaj Jere – Khaitan & Co.; Rohan Jhaveri – Khaitan & Co.; Kruthi Murthy – Khaitan & Co.; Noyonika Nair – Khaitan & Co.; Adheesh Nargolkar – Khaitan & Co.; Abhimanyu Pal – Khaitan & Co.; Niren Patel – Khaitan & Co.; Anshul Prakash – Khaitan & Co.; Lipi Rawat – Khaitan & Co.; Ravali Rayaprolu – Khaitan & Co.; Saswat Subasit – Khaitan & Co.; Abhilasha Vyas – Khaitan & Co.;

Law Firms: Khaitan & Co.;

Clients: True North Fund VI LLP ;